<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>p57KIP2 is a cyclin-dependent kinase inhibitor that maps to human chromosome band 11p15.5, placing it in a genomically imprinted region that has been implicated in the etiology of <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumor</z:e> and in the <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Recent analysis of p57KIP2 expression in the mouse has determined that this gene is exclusively expressed from the maternal allele </plain></SENT>
<SENT sid="2" pm="."><plain>It has been suggested that p57KIP2 is the WT2 <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene in the 11p15.5 region </plain></SENT>
<SENT sid="3" pm="."><plain>We have used reverse transcriptase PCR to determine whether loss of p57KIP2 expression occurs in <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumor</z:e> samples that have undergone maternal loss of heterozygosity of 11p15.5 </plain></SENT>
<SENT sid="4" pm="."><plain>p57KIP2 <z:chebi fb="2" ids="33699">mRNA</z:chebi> was amplified in both the <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumor</z:e> tissue and in <z:mpath ids='MPATH_458'>normal</z:mpath> kidney tissue of <z:hpo ids='HP_0000001'>all</z:hpo> five patients analyzed </plain></SENT>
<SENT sid="5" pm="."><plain>Semi-quantitative PCR analyses demonstrated that the relative level of p57KIP2 expression in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue is not markedly different from that in <z:mpath ids='MPATH_458'>normal</z:mpath> kidney </plain></SENT>
<SENT sid="6" pm="."><plain>Our data indicate that if the p57KIP2 gene is imprinted in humans and expressed exclusively from the maternal allele, reactivation of the paternal allele has occurred in <z:hpo ids='HP_0000001'>all</z:hpo> five <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumor</z:e> samples analyzed in this study </plain></SENT>
<SENT sid="7" pm="."><plain>Sequence analysis of the p57KIP2 Cdk inhibitory domain in genomic DNA from primary and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">secondary tumors</z:e> from two patients showed only a single base change in one secondary WT, resulting in a predicted methionine to isoleucine substitution at amino acid position 70 </plain></SENT>
<SENT sid="8" pm="."><plain>These studies suggest that p57KIP2 may not be the WT2 gene </plain></SENT>
</text></document>